Research indicates that the phenethylamine-dopamine D2 receptor-lysozyme signaling axis in the gut is a critical determinant of susceptibility to MS in female animals and young to middle-aged women, representing a novel extension of traditional perspectives (25). Here, DRD2 is linked to myeloid sarcoma.